In a report issued on August 3, Eric Fleming from SunTrust Robinson reiterated a Buy rating on Healthcare Trust (NYSE: HTA), with a price target of $32. The company’s shares closed on Friday at $28.24.
According to TipRanks.com, Fleming is a 4-star analyst with an average return of 9.6% and a 73.0% success rate. Fleming covers the Financial sector, focusing on stocks such as National Health Investors, Physicians Realty Trust, and Sabra Healthcare REIT.
Healthcare Trust has an analyst consensus of Moderate Buy, with a price target consensus of $29.40.
See today’s analyst top recommended stocks >>
Based on Healthcare Trust’s latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $15.35 million. In comparison, last year the company had a GAAP net loss of $5.92 million.
Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HTA in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Healthcare Trust of America, Inc. operates as an integrated, self-administered and self-managed real estate investment trust. It acquires, owns and operates medical office buildings and other facilities that serve the healthcare industry.
